Cargando…

Correlation between PPARG Pro12Ala Polymorphism and Therapeutic Responses to Thiazolidinediones in Patients with Type 2 Diabetes: A Meta-Analysis

Background: Thiazolidinediones (TZDs) are a type of oral drug that are utilized for the treatment of type 2 diabetes mellitus (T2DM). They function by acting as agonists for a nuclear transcription factor known as peroxisome proliferator-activated receptor-gamma (PPAR-γ). TZDs, such as pioglitazone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Eun Jeong, Lee, Da Hoon, Im, Sae-Seul, Yee, Jeong, Gwak, Hye Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303709/ https://www.ncbi.nlm.nih.gov/pubmed/37376225 http://dx.doi.org/10.3390/pharmaceutics15061778

Ejemplares similares

Diet and PPARG2 Pro12Ala Polymorphism Interactions in Relation to Cancer Risk: A Systematic Review
por: Tran, Lieu, et al.
Publicado: (2021)

Pro12Ala Polymorphism in the PPARG Gene Contributes to the Development of Diabetic Nephropathy in Chinese Type 2 Diabetic Patients
por: Liu, Limei, et al.
Publicado: (2010)

Prevalence of the Pro12Ala missense mutation in the PPARG2 gene in Kuwaiti patients with primary knee osteoarthritis
por: Al-Jarallah, Khaled F., et al.
Publicado: (2011)

PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis
por: Sarhangi, Negar, et al.
Publicado: (2020)

PPARG Pro12Ala Polymorphism with CKD in Asians: A Meta-Analysis Combined with a Case-Control Study—A Key for Reaching Null Association
por: Chen, Hsiang-Cheng, et al.
Publicado: (2020)

Effect of the PPARG2 Pro12Ala Polymorphism and Clinical Risk Factors for Diabetes Mellitus on HbA1c in the Japanese General Population
Publicado: (2012)

The Single Nucleotide Polymorphism PPARG2 Pro12Ala Affects Body Mass Index, Fat Mass, and Blood Pressure in Severely Obese Patients
por: Rodrigues, Ana Paula dos Santos, et al.
Publicado: (2018)

Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers
por: Kamble, Prasad G., et al.
Publicado: (2017)

Effect of the PPARG2 Pro12Ala Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes
por: Yates, Thomas, et al.
Publicado: (2015)

PPARG2 Pro12Ala polymorphism influences body composition changes in severely obese patients consuming extra virgin olive oil: a randomized clinical trial
por: Rodrigues, Ana Paula Santos, et al.
Publicado: (2018)

PPARγ2(Pro12Ala) Polymorphism and Human Health
por: He, Weimin
Publicado: (2009)

PPARG2 Pro12Ala and TNFα -308G>A Polymorphisms Are Not Associated with Heart Failure Development in Patients with Ischemic Heart Disease after Coronary Artery Bypass Grafting
por: Wojtkowska, Izabela, et al.
Publicado: (2019)

Breast-Feeding Modulates the Influence of the Peroxisome Proliferator–Activated Receptor-γ (PPARG2) Pro12Ala Polymorphism on Adiposity in Adolescents: The Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) cross-sectional study
por: Verier, Caroline, et al.
Publicado: (2010)

Homozygosity for the Ala Allele of the PPARγ2 Pro12Ala Polymorphism Is Associated with Reduced Risk of Coronary Artery Disease
por: Galgani, Andrea, et al.
Publicado: (2010)

Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?
por: Pereira, A. C., et al.
Publicado: (2013)

Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome
por: Zaki, Moushira, et al.
Publicado: (2017)

Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy
por: Chen, Yung‐Nien, et al.
Publicado: (2020)

OR14-05 Hepatocyte Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Offsets the Anti-Steatogenic Effects of Thiazolidinediones in Obese Male Mice
por: Muratalla, Jose T, et al.
Publicado: (2020)

Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk
por: Sanghera, Dharambir K, et al.
Publicado: (2008)

The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis
por: Gouda, Hebe N., et al.
Publicado: (2010)

Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy
por: Tariq, Khadija, et al.
Publicado: (2013)

Relationship of the Pro12Ala Polymorphism on the PPARy2 Gene With the Body Composition of Practitioners of Cyclic Exercises
por: da Silva, Raquel Suelen Brito, et al.
Publicado: (2021)

Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
por: Lee, Yeonhong, et al.
Publicado: (2022)

PPARγ Pro(12)Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes
por: Vogel, Ulla, et al.
Publicado: (2009)

PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome
por: Passaro, Angela, et al.
Publicado: (2011)

Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (Pro12Ala) in Iranian population
por: Namvaran, Fatemeh, et al.
Publicado: (2011)

Genetic polymorphism of Pro12Ala in type 2 diabetes mellitus: Role in inflammation linked to Insulin resistance
por: Bonam, Venkata Ramesh, et al.
Publicado: (2023)

Association of FTO and PPARG polymorphisms with obesity in Portuguese women
por: Carlos, Fábio Ferreira, et al.
Publicado: (2013)

Associations between PPARG polymorphisms and the risk of essential hypertension
por: Cai, Gaojun, et al.
Publicado: (2017)

The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis
por: Ding, Xiaoying, et al.
Publicado: (2020)

Associations of GNAS and RGS Gene Polymorphisms with the Risk of Ritodrine-Induced Adverse Events in Korean Women with Preterm Labor: A Cohort Study
por: Jang, Eun-Jeong, et al.
Publicado: (2022)

Peroxisome proliferator-activated receptor Pro12Ala polymorphism and the risks of gestational diabetes mellitus: An updated meta-analysis of 12 studies
por: Wang, Lihong, et al.
Publicado: (2016)

Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population
por: Ghoussaini, Maya, et al.
Publicado: (2005)

The Pro12Ala Polymorphism of PPAR-γ Gene Is Associated with Sepsis Disease Severity and Outcome in Chinese Han Population
por: Ma, Guoda, et al.
Publicado: (2014)

Association between the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene and Strength Athlete Status
por: Maciejewska-Karlowska, Agnieszka, et al.
Publicado: (2013)

Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis
por: Wei, Zhijiang, et al.
Publicado: (2015)

Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population
por: Bener, Abdulbari, et al.
Publicado: (2015)

PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes
por: Vales-Villamarín, Claudia, et al.
Publicado: (2021)

PPARG as therapeutic target for antifibrotic therapy
por: Ghallab, Ahmed, et al.
Publicado: (2020)

Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study
por: Kim, Jung Sun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ji3utjaqda6tfq9sj4tns4ekb